Systemic bevacizumab for recurrent respiratory papillomatosis: a national survey
SR Best, M Mohr, KB Zur - The Laryngoscope, 2017 - Wiley Online Library
Objectives/Hypothesis Aggressive laryngeal, tracheal, and pulmonary papilloma is an
extremely challenging clinical problem without proven treatment options. A recent German …
extremely challenging clinical problem without proven treatment options. A recent German …
Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey
SR Best, M Mohr, KB Zur - The Laryngoscope, 2017 - pubmed.ncbi.nlm.nih.gov
Objectives/hypothesis Aggressive laryngeal, tracheal, and pulmonary papilloma is an
extremely challenging clinical problem without proven treatment options. A recent German …
extremely challenging clinical problem without proven treatment options. A recent German …
Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey
SR Best, M Mohr, KB Zur - Laryngoscope, 2017 - pure.johnshopkins.edu
Objectives/Hypothesis: Aggressive laryngeal, tracheal, and pulmonary papilloma is an
extremely challenging clinical problem without proven treatment options. A recent German …
extremely challenging clinical problem without proven treatment options. A recent German …
Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey.
SR Best, M Mohr, KB Zur - The Laryngoscope, 2017 - europepmc.org
Methods Electronic survey of the RRP Task Force of the American Society of Pediatric
Otolaryngology, American Broncho-Esophagological Association, and physicians known to …
Otolaryngology, American Broncho-Esophagological Association, and physicians known to …
[HTML][HTML] Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A National Survey
SR Best, M Mohr, KB Zur - The Laryngoscope, 2017 - ncbi.nlm.nih.gov
Objective Aggressive laryngeal, tracheal and pulmonary papilloma is an extremely
challenging clinical problem without proven treatment options. A recent German report …
challenging clinical problem without proven treatment options. A recent German report …
[PDF][PDF] Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A National Survey
Laryngoscope, 2017 - academia.edu
Objective—Aggressive laryngeal, tracheal and pulmonary papilloma is an extremely
challenging clinical problem without proven treatment options. A recent German report …
challenging clinical problem without proven treatment options. A recent German report …
[引用][C] Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey
SR Best, M Mohr, KB Zur - The Laryngoscope, 2017 - cir.nii.ac.jp
Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …